In vitro and in vivo evaluation of a dextran-graft-polybutylmethacrylate copolymer coated on CoCr metallic stent
BioImpacts · 02.10.2018 · 9 (1) · 25-36
DOI: 10.15171/bi.2019.04 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioImpacts, online erschienen am 02.10.2018. Verfasst von Cécilia Delattre und 13 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, UMR_S1148, Laboratory for Vascular Translational Sciences, Hôpital Bichat. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
The major complications of stent implantation are restenosis and late stent thrombosis. PBMA polymers are used for stent coating because of their mechanical properties. We previously synthesized and characterized Dextrangraft-polybutylmethacrylate copolymer (Dex-PBMA) as a potential stent coating. In this study, we evaluated the haemocompatibility and biocompatibility properties of Dex-PBMA in vitro and in vivo.
Methods
Here, we investigated: (1) the effectiveness of polymer coating under physiological conditions and its ability to release Tacrolimus®, (2) the capacity of Dex-PBMA to inhibit Staphylococcus aureus adhesion, (3) the thrombin generation and the human platelet adhesion in static and dynamic conditions, (4) the biocompatibility properties in vitro on human endothelial colony forming cells ( ECFC) and on mesenchymal stem cells (MSC) and in vivo in rat models, and (5) we implanted Dex-PBMA and Dex-PBMATAC coated stents in neointimal hyperplasia restenosis rabbit model.
Results
Dex-PBMA coating efficiently prevented bacterial adhesion and release Tacrolimus®. Dex-PBMA exhibit haemocompatibility properties under flow and ECFC and MSC compatibility. In vivo, no pathological foreign body reaction was observed neither after intramuscular nor intravascular aortic implantation. After Dex-PBMA and Dex-PBMATAC coated stents 30 days implantation in a restenosis rabbit model, an endothelial cell coverage was observed and the lumen patency was preserved.
Conclusion
Based on our findings, Dex-PBMA exhibited vascular compatibility and can potentially be used as a coating for metallic coronary stents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- INSERM, UMR_S1148, Laboratory for Vascular Translational Sciences, Hôpital Bichat.
- Université Paris 13, Sorbonne Paris Cité, France.
- Inserm UMR_S1140, Paris France.
- Université Paris Descartes, Sorbonne Paris Cité, France.
Zitieren
APA
Delattre, C., Velazquez, D., Roques, C., Pavon-Djavid, G., Ollivier, V., Lokajczyk, A., Avramoglou, T., Gueguen, V., Louedec, L., Caligiuri, G., Jandrot-Perrus, M., Boisson-Vidal, C., Letourneur, D., & Meddahi-Pelle, A. (2018). In vitro and in vivo evaluation of a dextran-graft-polybutylmethacrylate copolymer coated on CoCr metallic stent. BioImpacts, 9(1), 25-36. https://doi.org/10.15171/bi.2019.04
Vancouver
Delattre C, Velazquez D, Roques C, Pavon-Djavid G, Ollivier V, Lokajczyk A, et al. In vitro and in vivo evaluation of a dextran-graft-polybutylmethacrylate copolymer coated on CoCr metallic stent. BioImpacts. 2018;9(1):25-36. doi:10.15171/bi.2019.04
BibTeX
@article{Delattre2018,
author = {Delattre, Cécilia and Velazquez, Diego and Roques, Caroline and Pavon-Djavid, Graciela and Ollivier, Véronique and Lokajczyk, Anna and Avramoglou, Thierry and Gueguen, Virginie and Louedec, Liliane and Caligiuri, Giuseppina and Jandrot-Perrus, Martine and Boisson-Vidal, Catherine and Letourneur, Didier and Meddahi-Pelle, Anne},
title = {In vitro and in vivo evaluation of a dextran-graft-polybutylmethacrylate copolymer coated on CoCr metallic stent},
journal = {BioImpacts},
year = {2018},
volume = {9},
number = {1},
pages = {25--36},
doi = {10.15171/bi.2019.04}
}
EUVIMED